COST OF DELIVERING INTRAVENEOUS OPIOID ANALGESIA IN EMERGENCY DEPARTMENTS IN THE UNITED STATES

Author(s)

Palmer PP1, Lemus B1, DiDonato K1, House J2
1AcelRx Pharmaceuticals, Inc., Redwood City, CA, USA, 2Premier, Inc, Charlotte, NC, USA

OBJECTIVES: Evaluation of the cost of delivering IV opioids in the emergency department (ED) for the treatment of acute pain has been limited to date.  This study estimates the cost of delivering an initial dose of an IV opioid to ED patients. METHODS: Descriptive analyses using the Premier database (2013-2014) of > 600 US hospital EDs were conducted on the cost of starting an IV and delivering an initial dose of an IV opioid in EDs.  Average costs of each component were aggregated for total costs.  Direct acquisition and indirect cost (labor, pharmacy, etc.) were included. RESULTS: Over 24 months, 7,327,299 patients received IV opioids in 614 EDs in the US (approximately one-tenth of EDs in the US).  Of these patients, 58% were not admitted to the hospital.  Morphine (56%), hydromorphone (45%) and fentanyl (25%) were the most frequently administered IV opioids.  Average [median; interquartile range] costs include initiating an IV ($62 [$62; $60-66]), IV catheter ($4 [$3; $2-3]), infusion pump tubing ($15 [$18; $8-21]), infusion pump to maintain IV patency ($37 [$26; $23-64]), 250 mL saline bag ($15 [$13; $9-19]), 2% lidocaine for local anesthesia for line placement ($5 [$4; $3-6]) and the cost of a single dose of morphine 5 mg ($6 [$4; $2-7]), hydromorphone 1 mg ($7 [$5; $3-9]) or fentanyl 100 mcg ($7 [$6; $4-10]).  Aggregated mean IV opioid total costs per patient for a single standard dose of opioid were $143 (morphine), $144 (hydromorphone) and $145 (fentanyl).   CONCLUSIONS: The cost of setting up an IV line to administer an opioid is substantial. Since the majority of patients receiving IV opioids are discharged from the ED, the ultimate use for this IV line is limited.  The development of a rapid-acting, non-invasive analgesic for ED use could be advantageous from both a cost and patient-benefit standpoint.

Conference/Value in Health Info

2016-05, ISPOR 2016, Washington DC, USA

Value in Health, Vol. 19, No. 3 (May 2016)

Code

PSY33

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Systemic Disorders/Conditions

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×